Skip to Main Content (Press Enter)

Logo UNIMI
  • ×
  • Home
  • Persone
  • Attività
  • Ambiti
  • Strutture
  • Pubblicazioni
  • Terza Missione

Expertise & Skills
Logo UNIMI

|

Expertise & Skills

unimi.it
  • ×
  • Home
  • Persone
  • Attività
  • Ambiti
  • Strutture
  • Pubblicazioni
  • Terza Missione
  1. Attività

Novel Testing Strategies for Endocrine Disruptors in the Context of Developmental NeuroToxicity (ENDpoiNTs)

Progetto
Clear evidence supports associations between endocrine disrupting chemical (EDC) exposure and impaired neurodevelopment. Yet, current hazard assessment of EDCs does not address developmental neurotoxicity. This is due to lack of scientific knowledge on how endocrine disruption is linked to developmental neurotoxicity (DNT). Thus there is an urgent need for novel testing and screening tools to address ED-induced DNT, based on new scientific knowledge. This calls for rapid advances in basic research as well as in the development of screening and testing tools close to the end-users. ENDpoiNTs will address this need by i) integrating advanced expertise in the EDC and DNT fields, two so far rather independent toxicology communities, and ii) continuous interaction with European and international key stakeholders. By combining state-of-the-art in silico and in vitro tools, innovative experimental designs and technologies, and advanced biostatistics on human epidemiological and biomonitoring data, ENDpoiNTs will 1) Generate the necessary scientific insights on the correlative and causal links between endocrine disruption and DNT; 2) Develop predictive in silico tools for chemical screening using machine learning and combination of evidence; 3) Develop and validate in vitro tools for chemical screening and testing that address sex- and species differences; 4) Develop novel molecular endpoints for existing animal-based test guidelines by integrating in vitro, in vivo, and human omics data with behavioural outcomes; 5) Ensure human relevance by linking experimental and epidemiological evidence; 6) Develop an integrated testing approach based on the developed in silico, in vitro, and in vivo assays and molecular markers; 7) Ensure regulatory relevance by developing strategies for implementation of these tools and endpoints into regulatory frameworks. In this way, ENDpoiNTs will meet the scientific, regulatory, and societal needs for improved hazard and risk assessment of EDCs
  • Dati Generali
  • Aree Di Ricerca
  • Pubblicazioni

Dati Generali

Partecipanti

TESTA GIUSEPPE   Responsabile scientifico  

Dipartimenti coinvolti

Dipartimento di Oncologia ed Emato-Oncologia   Principale  

Tipo

H20_RIA - Horizon 2020_Research & Innovation Action/Innovation Action

Finanziatore

EUROPEAN COMMISSION
Organizzazione Esterna Ente Finanziatore

Capofila

KAROLINSKA INSTITUTET

Periodo di attività

Gennaio 1, 2019 - Dicembre 31, 2023

Durata progetto

60 mesi

Aree Di Ricerca

Settori


Settore BIO/11 - Biologia Molecolare

Pubblicazioni

Pubblicazioni (3)

Autism spectrum disorder at the crossroad between genes and environment : contributions, convergences, and interactions in ASD developmental pathophysiology 
MOLECULAR AUTISM
BIOMED CENTRAL
2020
Articolo
Open Access
Altmetric disabilitato. Abilitalo su "Utilizzo dei cookie"
The endpoints project : novel testing strategies for endocrine disruptors linked to developmental neurotoxicity 
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
MDPI
2020
Articolo
Open Access
Altmetric disabilitato. Abilitalo su "Utilizzo dei cookie"
The sociability spectrum : Evidence from reciprocal genetic copy number variations 
MOLECULAR AUTISM
BIOMED CENTRAL
2020
Articolo
Open Access
Altmetric disabilitato. Abilitalo su "Utilizzo dei cookie"
  • Informazioni
  • Assistenza
  • Accessibilità
  • Privacy
  • Utilizzo dei cookie
  • Note legali

Realizzato con VIVO | Progettato da Cineca | 25.11.5.0